Showing Results for
- Academic Journals (612)
Search Results
- 612
Academic Journals
- 612
-
From:Colorectal Cancer (Vol. 1, Issue 3) Peer-ReviewedAuthor(s): Eric Assenat 1 Colorectal cancer (CRC) is the second leading cause of cancer-related death worldwide, with more than 200,000 deaths per year in Europe alone [1] . Over half of all patients with CRC will...
-
From:Nature Reviews Clinical Oncology (Vol. 7, Issue 10) Peer-ReviewedAdjuvant use of anthracycline-taxane combination therapy is an accepted strategy in the management of high-risk early-stage breast cancer. However, the introduction of this regimen raises the question of how best to...
-
From:Indian Journal of Cancer (Vol. 46, Issue 4) Peer-ReviewedByline: A. Jain, K. Sajeevan, K. Babu, K. Lakshmaiah Soft tissue sarcomas (STSs) are rare and histologically diverse neoplasms. Recent results of various meta-analyses and development of newer drugs have changed the...
-
From:Chest (Vol. 121, Issue 2) Peer-ReviewedStudy objectives: No established curative treatment is available for pleural thymoma metastases and malignant pleural mesothelioma (MPM). Recently, peritoneal malignancies have been treated by cytoreductive surgery and...
-
From:Science (Vol. 260, Issue 5112) Peer-ReviewedScientists are using multidrug combinations in an effort to overcome the resistance of the HIV virus to antiretroviral drugs. They hope that the HIV virus cannot mutate fast enough to develop immunity to all of the drugs...
-
From:Cancer Management and Research (Vol. 9) Peer-ReviewedObjective: The aim of this retrospective study was to evaluate the efficacy and prognostic factors of bortezomib and dexamethasone (BD) chemotherapy regimen in the treatment of newly diagnosed multiple myeloma (MM)...
-
From:Acta Dermatovenerologica Alpina, Pannonica et Adriatica (Vol. 27, Issue 4) Peer-ReviewedThis case study describes a 37-year-old Caucasian male with pruritic papules and plaques--some with central erosion--on the arms, neck, and trunk that appeared after chemotherapy with FOLFOX (folinic acid, fluorouacil,...
-
From:Case Reports in Oncology (Vol. 13, Issue 1) Peer-ReviewedDisseminated carcinomatosis of the bone marrow (DCBM) in colorectal cancer is an extremely rare complication with a poor prognosis. Here, we report a case of DCBM due to rectal cancer successfully treated with a...
-
From:Journal of Ovarian Research (Vol. 6, Issue 1) Peer-ReviewedBackground Ovarian cancer remains an on-going challenge mainly due to the development of drug resistance and also because the cancer is likely to have metastasized at the time of diagnosis. Currently, chemotherapy...
-
From:Cancer Gene Therapy (Vol. 28, Issue 6) Peer-ReviewedAuthor(s): Teresa Gagliano 1 , Claudio Brancolini 1 Author Affiliations: (1) Department of Medicine, University of Udine, Udine, Italy Neuroendocrine tumors (NETs) are relatively rare neoplasm that arise from cells...
-
From:BMC Cancer (Vol. 21, Issue 1) Peer-ReviewedBackground Gemcitabine plus platinum as the first-line chemotherapy for cholangiocarcinoma (CCA) has limited efficacy. The aim of this study was to evaluate the effectiveness of modified FOLFIRINOX (mFOLFIRINOX)...
-
From:Nanomedicine (Vol. 6, Issue 1) Peer-ReviewedAuthor(s): John W Stone 1 , James E Crowe [[dagger]] 2 Evaluation of: Krpetic Z, Nativo P, Sée V, Prior IA, Brust M, Volk M: Inflicting controlled nonthermal damage to subcellular structures by laser-activated gold...
-
From:Molecular Diagnosis & Therapy (Vol. 13, Issue 6) Peer-ReviewedA 61-year-old woman with multiple myeloma developed acute lymphoblastic leukemia (ALL) with mixed-lineage leukemia gene (MLL) rearrangement after receiving cyclophosphamide and melphalan [durations of therapies not...
-
From:Oncology Nursing Forum (Vol. 36, Issue 1) Peer-ReviewedPurpose/Objectives: To review available data and implications for nurses of combination regimens containing capecitabine for metastatic breast cancer. Data Sources: Peer-reviewed publications or abstracts from major...
-
From:Oncology (Vol. 24, Issue 12) Peer-ReviewedDespite the fact that elderly patients comprise over 50% of the non-small cell lung cancer (NSCLC) population, our knowledge regarding the efficacy and safety of chemotherapy in this group is suboptimal. The "elderly"...
-
From:Nature Clinical Practice Oncology (Vol. 3, Issue 7) Peer-ReviewedPfreundschuh M et al . (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera...
-
From:Nature Reviews Clinical Oncology (Vol. 7, Issue 4) Peer-ReviewedRecent evidence indicates that the novel 20S proteasome inhibitor NPI-0052 (Marizomib) triggers apoptosis in multiple myeloma (MM) cells, when given in combination with the immunomodulatory agent lenalidomide. This is...
-
From:PLoS ONE (Vol. 15, Issue 12) Peer-ReviewedImprovements in survival rates with gonad-sparing protocols for childhood and adolescence cancer have increased the optimism of survivors to become parents after treatment. Findings in rodents indicate that chromosomal...
-
From:Oncology Nurse AdvisorGemcitabine plus cisplatin significantly improved overall survival (OS) when compared with fluorouracil plus cisplatin in treatment-naïve patients with advanced nasopharyngeal carcinoma, according to final results of a...
-
From:Molecular and Clinical Oncology (Vol. 3, Issue 2) Peer-ReviewedMalignant pleural effusion (MPE) is a common complication of lung cancer with devastating consequences. Since vascular endothelial growth factor (VEGF) has been implicated in MPE, we hypothesized that bevacizumab, an...